Chendi Gu

发表

Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.

P. Tonge, R. Slayden, Susan E. Knudson, 2016, Journal of medicinal chemistry.

Structure-Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors.

P. Tonge, Yong Li, F. Daryaee, 2022, Journal of medicinal chemistry.

Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells.

Yan Peng, Jing-Mei Yuan, Gui-Fa Su, 2017, Journal of medicinal chemistry.

Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.

Jing-Mei Yuan, Gui-Fa Su, Guo-Hai Zhang, 2019, European journal of medicinal chemistry.

Gold-Catalyzed Selective 6-exo-dig and 7-endo-dig Cyclizations of Alkyn-Tethered Indoles To Prepare Rutaecarpine Derivatives.

Gui-Fa Su, Feng Zhan, Chendi Gu, 2018, The Journal of organic chemistry.